Overview

ATAC - Pharmacokinetics (PK) Sub-Protocol

Status:
Completed
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
To assess the effect of ARIMIDEX on the pharmacokinetics of tamoxifen and the effects of tamoxifen on the pharmacokinetics of ARIMIDEX..
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anastrozole
Tamoxifen